Furthermore, if the results obtained confirm the safety of FluMist® in egg-allergic patients, this will allow reassurance of healthcare professional of the safety of vaccination in egg-allergic patients. More long term, this will allow egg-allergic patients to receive the LAIV rather than being limited to TIV.